Atherectomy Devices Market Report
First published: 12 October 2024 | Last updated: 25 May 2026 | Report Code: atherectomy-devices
Atherectomy Devices Market — USD 1.2 billion in 2023, Growing to USD 3.10B by 2033 at 9.6% CAGR
This report provides an exhaustive analysis of the Atherectomy Devices market, exploring trends, regional dynamics, competitive landscapes, and future forecasts from 2023 to 2033.
Key Takeaways
- Global market value expands from $1.20 Billion in 2023 to $3.10 Billion in 2033 at a 9.6% CAGR over 2023 to 2033.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Regional growth is broad-based with Europe rising from $0.29 Billion to $0.74 Billion and Asia Pacific from $0.25 Billion to $0.65 Billion.
- Device-type diversity includes directional, rotational, laser, and orbital atherectomy systems across hospitals and specialty centers.
- Key companies listed include Boston Scientific Corporation, Medtronic, Abbott Laboratories, and C.R. Bard.
Atherectomy Devices Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report evaluates the global atherectomy devices market over the 2023 to 2033 forecast period, where market value increases from $1.20 Billion to $3.10 Billion at a 9.6% CAGR. Growth drivers include rising cardiovascular disease prevalence, an aging population, greater adoption of minimally invasive vascular interventions, and ongoing device innovation. The study breaks the market into device types — directional, rotational, laser, and orbital — as well as applications such as coronary and peripheral atherosclerosis and thrombus removal, and end-users including hospitals, ambulatory surgery centers, and specialty clinics. North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The report also profiles leading vendors including Boston Scientific Corporation, Medtronic, Abbott Laboratories, and C.R. Bard, and presents segment-level insights to guide strategy and investment decisions.
Key Growth Drivers
- Increasing prevalence of cardiovascular diseases raising demand for interventional treatments.
- Greater preference for minimally invasive procedures that favor atherectomy use in vascular care.
- Technological enhancements and product innovation improving procedural outcomes and adoption.
- Expanded access to healthcare services and higher procedure volumes in established markets.
- Investment by leading manufacturers boosting device availability and clinical adoption.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $1.20 Billion |
| CAGR (2023-2033) | 9.6% |
| 2033 Market Size | $3.10 Billion |
| Top Companies | Boston Scientific Corporation, Medtronic , Abbott Laboratories, C.R. Bard |
| Published Date | 12 October 2024 |
| Last Modified Date | 25 May 2026 |
Atherectomy Devices Market Overview
Customize Atherectomy Devices Market Report market research report
- ✔ Get in-depth analysis of Atherectomy Devices market size, growth, and forecasts.
- ✔ Understand Atherectomy Devices's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Atherectomy Devices
What is the Market Size & CAGR of Atherectomy Devices Market Report market in 2023?
Atherectomy Devices Industry Analysis
Atherectomy Devices Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Atherectomy Devices Market Report Market Analysis Report by Region
Europe Atherectomy Devices Market Report:
Europe grows from $0.29 Billion in 2023 to $0.74 Billion in 2033. This increase reflects improving access to interventional care, ongoing adoption of minimally invasive techniques, and investments in cardiovascular treatment capabilities.Asia Pacific Atherectomy Devices Market Report:
Asia Pacific grows from $0.25 Billion in 2023 to $0.65 Billion in 2033. Growth drivers include rising healthcare spending, expanding access to advanced vascular procedures, and growing awareness of cardiovascular disease management.North America Atherectomy Devices Market Report:
North America is largest regional market, rising from $0.45 Billion in 2023 to $1.16 Billion in 2033. Regional expansion is supported by established healthcare infrastructure, higher procedural volumes, and adoption of advanced interventional devices.South America Atherectomy Devices Market Report:
Latin America grows from $0.08 Billion in 2023 to $0.2 Billion in 2033. Market gains are linked to greater availability of interventional services, improving healthcare infrastructure, and increasing procedure adoption in urban centers.Middle East & Africa Atherectomy Devices Market Report:
Middle East and Africa grows from $0.13 Billion in 2023 to $0.34 Billion in 2033. Expansion is attributed to improving medical infrastructure, increased access to specialist care, and gradual adoption of advanced vascular technologies.Tell us your focus area and get a customized research report.
Research Methodology
Atherectomy Devices Market Analysis By Device Type
The market segmentation by device type includes directional, rotational, laser, and orbital atherectomy devices. In 2023, directional atherectomy devices comprise a substantial share, valued at $0.65 billion, and are projected to rise to $1.69 billion by 2033. Rotational devices currently stand at $0.25 billion, expected to grow to $0.64 billion, illustrating increasing acceptance due to their effectiveness. Meanwhile, laser and orbital devices maintain niche positions with shares of $0.14 billion and $0.16 billion respectively in 2023, rising steadily by 2033.
Atherectomy Devices Market Analysis By Application
The application-based segmentation showcases coronary atherosclerosis dominating the market, accounting for $0.81 billion in 2023 and projected to reach $2.10 billion by 2033. Peripheral atherosclerosis follows with a size of $0.29 billion in 2023 and expected growth patterns similar to coronary applications, driven by increased interventions.
Atherectomy Devices Market Analysis By End User
Hospitals are the primary end-user, representing $0.81 billion in 2023 and anticipated to grow to over $2.10 billion by 2033, reflecting their utilitarian role in complex cardiovascular procedures. Ambulatory Surgery Centers and specialty clinics lead in specific segments, anticipated to account for $0.29 billion and $0.10 billion respectively, with robust growth portfolios as outpatient care expands.
Atherectomy Devices Market Analysis By Region
Regional insights underscore North America's dominance in the market, expected to hold a steady share. Europe is also marking significant growth indicating solid investment in cardiovascular care. Emerging markets in Asia-Pacific and Latin America are increasingly participating, fostering competitive dynamics and innovation within the sector.
Atherectomy Devices Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Atherectomy Devices Industry
Boston Scientific Corporation:
A leading company in the medical devices arena, Boston Scientific is known for its broad range of innovative products that enhance patient care quality in cardiovascular health.Medtronic :
Medtronic operates at the forefront of medical technology with a robust portfolio of cardiovascular devices including atherectomy systems, fostering improved treatment outcomes.Abbott Laboratories:
Abbott is a key player providing outstanding atherectomy solutions while focusing on advanced research to pioneer next-generation cardiovascular products.C.R. Bard:
C.R. Bard specializes in innovative device technologies, establishing impressive market presence through significant contributions to the atherectomy devices landscape.We're grateful to work with incredible clients.
FAQs
What is the market size of the atherectomy devices market in 2023?
The market size in 2023 is $1.20 Billion, as stated in the report data for the baseline year.
What is the projected market size in 2033?
The market is projected to reach $3.10 Billion by 2033 according to the provided forecast figures.
What is CAGR for the market during the forecast?
The report specifies a compound annual growth rate (CAGR) of 9.6% for the 2023 to 2033 period.
Is there a single fastest Growing region in the Atherectomy Devices Market Report market?
No single fastest-growing region is stated for the Atherectomy Devices Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Who are the top companies in the market?
Top companies listed in the input include Boston Scientific Corporation, Medtronic, Abbott Laboratories, and C.R. Bard.
Why is demand rising for atherectomy devices?
Demand is driven by higher cardiovascular disease incidence, aging populations, and growing use of minimally invasive vascular interventions.
How is the market segmented by device type?
Device-type segmentation in the report includes directional, rotational, laser, and orbital atherectomy devices as listed.
What end Users are covered in the report?
End-user segments include hospitals, ambulatory surgery centers, and specialty clinics as specified in the input data.